Merck & Co Inc
NYSE: MRK
$99.25
-$0.60 (-0.6%)
Closing Price on January 10, 2025
MRK Articles
Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can run, regardless of market conditions. One has to wonder if Endocyte is among the next...
Published:
States, often burdened by budget deficits that grew during the recession, are not getting tax receipts from some of America's largest companies. Among them are Boeing and Merck, which did not pay...
Published:
ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when it comes to the top high-yield safe dividends out there. Some of the changes...
Published:
The pricier the stock market gets, the more important it is for investors to keep a close eye on what they are paying for stocks. Flashy momentum stocks are great for traders, but investors need...
Published:
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events...
Published:
Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer immunotherapy...
Published:
Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to dazzle. But shares traded higher in the premarket session.
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014. They include Chevron, Gap, Merck, Microsoft and Zynga.
Published:
The 30 stocks comprising the Dow Jones Industrial Average combined to post a loss of just over 4.5% in January. Only four of the blue chip stocks managed to post a gain for the month, and they did so...
Published:
Last Updated:
thinkstockJanuary 27, 2014: Markets opened slightly higher on Monday and equities spent the day bouncing around the breakeven line. Tech stocks trailed behind, never quite rising above breakeven...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The stock market was pounded on Friday, making for a...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockWednesday was yet another mixed day in the...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Jon OggThe markets had only a small employment report...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Jon OggWe are now well past the end of 2013, and many...
Published:
With a new year comes new expectations. 24/7 Wall St. has generated a bullish and bearish scenario for 2014 in each stock of the Dow, including Pfizer and rival Merck & Co.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.